The entity exhibits poor cash conversion efficiency, characterized by a persistent negative free cash flow trajectory and an OCF/NI ratio that reached a low of -2.13 in 2025Q2.
| Cash from Operations | -3.55M | -3.41M | -1.32M |
| Operating CF Margin % | - | - | - |
| Operating CF Growth % | -1094.2% | -158.35% | - |
| Net Income | 7.34M | 8.56M | 8.79M |
| Depreciation & Amortization | 0 | 0 | 0 |
| Stock-Based Compensation | 0 | 0 | 0 |
| Deferred Taxes | 0 | 0 | 0 |
| Other Non-Cash Items | -11.62M | -12.49M | -9.58M |
| Working Capital Changes | 727.6K | 527.95K | -533.18K |
| Change in Receivables | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 |
| Change in Payables | 0 | 0 | 0 |
| Cash from Investing | 1M | 1M | -286.5M |
| Capital Expenditures | 0 | 0 | 0 |
| CapEx % of Revenue | - | - | - |
| Acquisitions | 0 | - | - |
| Investments | 310.26M | 307.62M | 296.12M |
| Other Investing | 1M | 1M | -286.5M |
| Cash from Financing | 500K | 0 | 290.23M |
| Debt Issued (Net) | 0 | - | - |
| Equity Issued (Net) | 0 | 0 | 289M |
| Dividends Paid | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 1.55M |
| Net Change in Cash | -2.05M | -2.41M | 2.41M |
| Free Cash Flow | -3.55M | -3.41M | -1.32M |
| FCF Margin % | - | - | - |
| FCF Growth % | -134.85% | -158.35% | - |
| FCF per Share | -0.12 | -0.12 | -0.05 |
| FCF Conversion (FCF/Net Income) | -0.48x | -0.40x | -0.15x |
| Interest Paid | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 |
Liquidation and Dilution Risk
According to the provided financial data, CCIXW consistently reports positive net income while simultaneously generating negative operating cash flow, with the OCF/NI ratio reaching a low of -2.13 in 2025Q2, indicating that reported earnings are entirely decoupled from the entity's actual cash-generating capabilities as a shell.
The persistent divergence between accounting net income and operating cash flow suggests that the entity's reported profitability is driven by non-cash or non-operating items rather than core business activity. Investors should monitor this gap, as it implies that the entity is consuming its limited capital reserves to fund administrative overhead despite the appearance of positive earnings.
As reported in quarterly financial statements, the entity has failed to generate positive free cash flow in any period since 2024Q1, with cash outflows reaching $334.7K in 2026Q1, confirming a steady erosion of capital as the sponsor continues its search for a viable acquisition target.
The consistent negative free cash flow trajectory reflects the structural reality of a SPAC that must fund ongoing compliance and administrative costs without any offsetting operational revenue. This trend warrants investigation, as the lack of positive cash flow generation places increasing pressure on the sponsor to secure a merger before the trust capital is depleted.
Based on the reported figures, working capital changes have been highly erratic, swinging from a positive $818.5K in 2026Q1 to a negative $781.3K in 2024Q2, which suggests that the entity's cash management is subject to significant fluctuations related to the timing of professional service payments.
These volatile working capital movements appear to be a byproduct of the entity's reliance on external service providers for legal and audit functions. The lack of a stable working capital cycle is typical for a shell company, yet it highlights the operational fragility inherent in the current pre-combination structure.
As indicated by the financial statements, the cash flow statement fails to account for the massive potential dilution from the sponsor promote, which remains hidden from the cash flow narrative despite being the most significant factor impacting the future value of the warrants for public investors.
The cash flow statement provides a narrow view of the entity's liquidity, focusing on administrative burn while ignoring the structural dilution that will occur upon a successful business combination. Investors should be wary of relying solely on these cash flow metrics, as they do not capture the full economic impact of the sponsor's equity stake.
Quick answers to the most common questions about buying CCIXW stock.
Churchill Capital Corp IX Warrant (CCIXW) generated $-3.4M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.
Churchill Capital Corp IX Warrant (CCIXW) reported negative free cash flow of $3.4M in 2025, indicating capital requirements exceeded cash from operations.
Churchill Capital Corp IX Warrant (CCIXW) spent $0.0M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.